International Journal of Molecular Sciences | |
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor Microenvironment | |
Daniel M. Berney1  Stefania Croci2  Martina Bonacini2  Carolina Castro Ruiz3  Jatin Gandhi4  Alessandra Soriano5  Sofia Cañete-Portillo6  Dario De Biase7  Alcides Chaux8  Giuseppe Carrieri9  Luigi Cormio9  Beatrice Melli1,10  Guido Giordano1,11  Matteo Landriscina1,11  Antonio De Leo1,12  Stefano Ascani1,13  Moira Ragazzi1,14  Giacomo Santandrea1,14  Maria Paola Bonasoni1,14  Giuditta Bernardelli1,14  Eleonora Zanetti1,14  Alessandra Bisagni1,14  Magda Zanelli1,14  Valerio Copelli1,14  Andrea Palicelli1,14  Francesca Sanguedolce1,15  Maurizio Zizzo1,16  | |
[1] Barts Cancer Institute, Queen Mary University of London, London EC1M 5PZ, UK;Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy;Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, 41121 Modena, Italy;Department of Pathology and Laboratory Medicine, University of Washington, Seattle, WA 98195, USA;Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA;Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA;Department of Pharmacy and Biotechnology (FABIT), University of Bologna, 40126 Bologna, Italy;Department of Scientific Research, School of Postgraduate Studies, Norte University, Asunción 1614, Paraguay;Department of Urology and Renal Transplantation, University of Foggia, 71122 Foggia, Italy;Fertility Centre, Department of Obstetrics and Gynecology, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy;Medical Oncology Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy;Molecular Diagnostic Unit, Azienda USL Bologna, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, 40138 Bologna, Italy;Pathology Unit, Azienda Ospedaliera Santa Maria di Terni, University of Perugia, 05100 Terni, Italy;Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy;Pathology Unit, Policlinico Riuniti, University of Foggia, 71122 Foggia, Italy;Surgical Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy; | |
关键词: PD-L1; prostate; cancer; signaling pathways; tumor microenvironment; target-therapy; | |
DOI : 10.3390/ijms222212330 | |
来源: DOAJ |
【 摘 要 】
The tumor microenvironment (TME) includes immune (T, B, NK, dendritic), stromal, mesenchymal, endothelial, adipocytic cells, extracellular matrix, and cytokines/chemokines/soluble factors regulating various intracellular signaling pathways (ISP) in tumor cells. TME influences the survival/progression of prostate cancer (PC), enabling tumor cell immune-evasion also through the activation of the PD-1/PD-L1 axis. We have performed a systematic literature review according to the PRISMA guidelines, to investigate how the PD-1/PD-L1 pathway is influenced by TME and ISPs. Tumor immune-escape mechanisms include suppression/exhaustion of tumor infiltrating cytotoxic T lymphocytes, inhibition of tumor suppressive NK cells, increase in immune-suppressive immune cells (regulatory T, M2 macrophagic, myeloid-derived suppressor, dendritic, stromal, and adipocytic cells). IFN-γ (the most investigated factor), TGF-β, TNF-α, IL-6, IL-17, IL-15, IL-27, complement factor C5a, and other soluble molecules secreted by TME components (and sometimes increased in patients’ serum), as well as and hypoxia, influenced the regulation of PD-L1. Experimental studies using human and mouse PC cell lines (derived from either androgen-sensitive or androgen-resistant tumors) revealed that the intracellular ERK/MEK, Akt-mTOR, NF-kB, WNT and JAK/STAT pathways were involved in PD-L1 upregulation in PC. Blocking the PD-1/PD-L1 signaling by using immunotherapy drugs can prevent tumor immune-escape, increasing the anti-tumor activity of immune cells.
【 授权许可】
Unknown